
Opinion|Videos|December 2, 2024
VMS Treatment Guidelines
Panelists discuss key considerations for women taking hormonal therapy, emphasizing the importance of individualized treatment plans and shared decision-making to evaluate the risk-benefit profile of therapy.
Advertisement
Episodes in this series

Individualized therapy with shared decision-making is essential when evaluating the risk-benefit profile of hormonal therapy. What are some key considerations for a woman taking hormonal therapy?
Advertisement
Related to this article

Wen Shen, MD, describes perimenopause as an opportunity for clinicians to revisit pregnancy-related risk factors and address cardiovascular health proactively.

A recap of the top videos and podcasts from Contemporary OB/GYN in September 2026, featuring expert interviews on salpingectomy, testosterone evidence, and more.

A new study finds that low birth volume and unprofitability were strongly associated with both obstetric unit and full hospital closures between 2010 and 2023.

A recap of the top headlines from Contemporary OB/GYN in September 2026, spanning ACOG's respiratory vaccine guidance to the launch of the Missed & Dismissed podcast.

Fezolinetant was linked to VMS and sleep improvements by week 4 in the real-world OPTION-VMS study, presented at the International Menopause Society World Congress.

Wen Shen, MD, highlights perimenopause as an important period for identifying health risks and supporting healthy aging beyond the menopausal transition.
Advertisement
Advertisement
Trending on Contemporary OB/GYN
1
Wen Shen, MD, highlights pregnancy, comorbidity history in perimenopause care
2
IMS: Fezolinetant's improvements in sleep quality, hot flashes as early as week 4
3
Preeclampsia Foundation launches postpartum recovery videos for HDP
4
Top headlines in women's health from September 2026
5


